Prof G's MS-Selfie

Time matters: should British people with MS accept sup-optimal care?Listen now (11 min) | In the #AttackMS trial we are comparing starting natalizumab within 2 weeks of symptom onset to those starting natalizumab after 2 months. Yes, we really think time matters in MS.
Comment15
Share
NewTopCommunity
Case study: how much brain have you lost?Listen now (14 min) | My neurologist, refuses to tell me if I have brain atrophy or not. He says the neuroradiologists don’t measure it, and even if…
Comment8
Share
Should this patient be prescribed siponimod for SPMS?
Comment32
Share
Can you have a relapse affecting the same site?Listen now (8 min) | Rebound post-natalizumab may be in response to EBV infected B-cells and plasma cells in the brains of people with MS. I am…
Comment15
Share
What is on the horizon for MS?Watch now (61 min) | Treating MS to a target beyond NEIDA (no evident inflammatory disease activity) and holistically should become the new norm. Do you…
Comment36
Share
What is my neurofilament level doing?Listen now (14 min) | The FDA has granted the plasma NFL assay Breakthrough Device designation as a prognostic aid in assessing patients with…
Comment6
Share
It is not good enough to simply target stabilisation or slowing down of disability worsening. I want to participate in a trial that offers an…
Comment39
Share
Waist-to-height ratio, metabolic health and MSListen now (11 min) | Healthcare professionals should be able to look you in the eye and say “I am with you all the way”. Do they?
Comment20
Share
See all

Prof G's MS-Selfie

AboutArchiveAuthors
© 2022 Gavin Giovannoni
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing